OSD on Part 3: Multi-omics Integration into Clinical Decision Making

When:  Jul 18, 2024 from 12:00 to 13:00 (ET)

The Biomarkers and Precision Medicine (BPM) and Bioanalytical (BA) Communities are hosting a series of Open Scientific Discussions (OSDs) on Multi-omics in Drug Development.    Please join us for the third OSD in the series on July 18th, 12 - 1 pm ET:

Part 3: Multi-omics Integration into Clinical Decision Making

·         What does the present regulatory environment look like for the application of multi-omics in clinical decision-making?

·         What challenges and considerations does multi-omics testing face, especially for adoption of MS-based proteomics, in clinical studies?

·         Case studies where multi-omics approaches have impacted clinical decision makings will be presented.

Discussion Leaders:

Robert Schuck (FDA) & Yuehan Feng (Biognosys)

Organized by:  Jurre Kamphorst (Olaris), Iris Qiu (Novartis), Ayuko Ota-Selik (Regeneron) and Jianing Zeng (BMS)


We start at 12:00 ET sharp. To avoid interruptions, please dial in before noon and mute yourself until Q&A starts.

(Please remain on mute unless asking questions)

When: Tuesday, July 18, 2024, 12 pm – 1 pm ET

WherePlease join from your computer, tablet or smartphone.

Download to Your Calendar Outlook Google


Carmen Fernandez-Metzler

[email protected]